Showing 14,361 - 14,380 results of 34,357 for search '(( 50 ((teer decrease) OR (a decrease)) ) OR ( 5 ((point decrease) OR (nn decrease)) ))', query time: 0.58s Refine Results
  1. 14361

    Presentation_1_Red Blood Cell Abnormalities as the Mirror of SARS-CoV-2 Disease Severity: A Pilot Study.PPTX by Anthi Bouchla (9748362)

    Published 2022
    “…Surprisingly, patients’ RBC-iROS were decreased, a finding possibly related with the increased G6PDH levels in this group, suggesting a possible compensatory mechanism against the virus. …”
  2. 14362

    Supplementary Material for: GLPG2737, a CFTR Inhibitor, Prevents Cyst Growth in Preclinical Models of Autosomal Dominant Polycystic Kidney Disease by figshare admin karger (2628495)

    Published 2025
    “…Results: GLPG2737 inhibited chloride flux in mIMCD-3 cells with an IC50 of 2.41 µM. In a 3D assay, GLPG2737 inhibited cyst growth in both wild-type (IC50 = 2.36 µM) and Pkd1 knockout (IC50 = 2.5 µM) mIMCD-3 cells. …”
  3. 14363

    <i>In Vitro</i> and <i>In Vivo</i> Antifungal Activity of Lichochalcone-A against <i>Candida albicans</i> Biofilms - Fig 5 by Dalia Seleem (2827508)

    Published 2016
    “…<i>albicans</i> enzymes secretion expressed in U/grams of dry weight after treatment with lichochalcone-A at concentrations of 625 μM and 1500 μM: <b>A.…”
  4. 14364
  5. 14365

    Variation law of UCS. by Wenyu Lv (20139458)

    Published 2025
    “…Notably, the attenuation constant λ follows a monotonically decreasing pattern with increasing loading rate. …”
  6. 14366
  7. 14367
  8. 14368
  9. 14369
  10. 14370
  11. 14371
  12. 14372
  13. 14373
  14. 14374
  15. 14375

    Supplementary Material for: Vitamin D status and treatment in ESKD; links to improved CKD-MBD laboratory parameters in a real-world setting by Holden R.M. (3346661)

    Published 2024
    “…Laboratory parameters were measured every 6 (phosphate, calcium) or 12 weeks (25(OH)D3, PTH, ALP) until February, 2021. In September, 2018 a treatment algorithm of 50,000 IU weekly until sufficient, followed by 50,000 IU monthly was suggested. …”
  16. 14376

    Self-paced combined training alleviated oxidative stress, inflammatory responses and hyperlipidaemia in people living with multiple sclerosis: a randomised controlled trial by Sonda Jallouli (20484146)

    Published 2024
    “…</p> <p><b>Results:</b> Comparatively with CG, the TG showed a decrease in advanced oxidation protein products (p = 0.002, Hedges’g (g) = 1.50) and total thiols (p = 0.0011, g = 1.57), as well as an increase in reduced glutathione (p = 0.03, g = 0.98). …”
  17. 14377

    DataSheet_1_A first-in-human, open-label, dose-escalation and dose-expansion phase I study to evaluate the safety, tolerability, pharmacokinetics/pharmacodynamics, and antitumor ac... by Zhiyu Huang (638377)

    Published 2023
    “…Background<p>QL1604 is a humanized immunoglobulin G4 monoclonal antibody against programmed cell death protein 1. …”
  18. 14378
  19. 14379
  20. 14380